L'Oreal says weight loss drugs are impacting beauty and skincare sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
Àkótán ìròyìn
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
Tẹ̀lé ìròyìn tuntun láti ọ̀dọ̀ àwọn olùtẹ̀jáde tó ṣeé gbẹ́kẹ̀lé pẹ̀lú àkótán kúkúrú. Ṣí ìjápọ̀ orísun àtilẹ̀wá fún àlàyé.